Klinger, Bertram <br/><br/>
Network quantification of EGFR signaling unveils potential for targeted combination therapy.  [electronic resource] 

 -  Molecular systems biology  2013 
 - 673 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1744-4292 
<br/><br/><label>Standard No.: </label>10.1038/msb.2013.29  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Cell Line, Tumor<br/>Colorectal Neoplasms--drug therapy<br/>Drug Screening Assays, Antitumor<br/>Drug Therapy, Combination<br/>ErbB Receptors--genetics<br/>Extracellular Signal-Regulated MAP Kinases--genetics<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Mice<br/>Mice, Nude<br/>Models, Genetic<br/>Phosphatidylinositol 3-Kinases--genetics<br/>Protein Interaction Maps--drug effects<br/>Protein Kinase Inhibitors--pharmacology<br/>Proto-Oncogene Proteins B-raf--genetics<br/>Proto-Oncogene Proteins c-akt--genetics<br/>Signal Transduction--drug effects<br/>Transplantation, Heterologous<br/>Tumor Burden--drug effects<br/>ras Proteins--genetics